Percutaneous Removal of Benign Breast Lesions with an Ultrasound-guided Vacuum-assisted System:Influence Factors in the Hematoma Formation

Objective To explore the influence factors in hematoma formation after removing benign breast lesions with an ultrasound-guided vacuum-assisted system.Methods A total of 232 females with 312 benign breast masses received excisional biopsy with ultrasoundguided vacuum-assisted system.The pathology of patients,results of hematoma development and outcome,influence factors for hematoma occurrence(nodule size,nodule location,number of nodule,breast shape,menstrual period,efficacy time of bandage,and application of hemostatic agents during the procedure) were recorded.Results Pathologic examination revealed fibroadenomas in 138 lesions,fibroadenosis in 127 lesions,intraductal papillomas in 39 lesions,inflammatory change in 4 lesions,retention cyst of the breast in 3 lesions,and benign phyllodes tumor in 1 lesion.Thirty hematomas were observed in patients(9.6%).Finally,97.0%hematomas were absorbed completely within 6 months follow-up.The incidence rates of hematoma were increased by 24.7%,10.0%,63.2%,13.9%in the nodule diameter larger or equal to 25 mm group,removal of larger or equal to two nodules once time from one patient group,menstrual period group,and larger and loose breast group,respectively(all P<0.05).However,the incidences were decreased by 60.6%in the bandage performed for 12-24 hours or beyond 24 hours group(P<0.05).The multiple logistic regression models revealed that nodule size(x^2=15.227,P<0.001),number of nodule(x^2=7.767,P=0.005),menstrual period(x^2=24.530,P<0.001),and breast shape(x^2=9.559,P=0.002) were independent risk factors associated with hematoma occurrence,but efficacy time of bandage was a protective factor associated with hematoma occurrence.Conclusion The occurrence of hematoma after the minimally invasive operation was associated with nodule size,number of nodule,menstrual period,breast shape,and efficacy time of bandage.

Neuroprotective effects of ultrasound-guided nerve growth factor injections after sciatic nerve injury

Nerve growth factor（NGF） plays an important role in promoting neuroregeneration after peripheral nerve injury. However, its effects are limited by its short half-life; it is therefore important to identify an effective mode of administration. High-frequency ultrasound（HFU） is increasingly used in the clinic for high-resolution visualization of tissues, and has been proposed as a method for identifying and evaluating peripheral nerve damage after injury. In addition, HFU is widely used for guiding needle placement when administering drugs to a specific site. We hypothesized that HFU guiding would optimize the neuroprotective effects of NGF on sciatic nerve injury in the rabbit. We performed behavioral, ultrasound, electrophysiological, histological, and immunohistochemical evaluation of HFU-guided NGF injections administered immediately after injury, or 14 days later, and compared this mode of administration with intramuscular NGF injections. Across all assessments, HFU-guided NGF injections gave consistently better outcomes than intramuscular NGF injections administered immediately or 14 days after injury, with immediate treatment also yielding better structural and functional results than when the treatment was delayed by 14 days. Our findings indicate that NGF should be administered as early as possible after peripheral nerve injury, and highlight the striking neuroprotective effects of HFU-guided NGF injections on peripheral nerve injury compared with intramuscular administration.

Left bundle branch pacing with optimization of cardiac resynchronization treatment:A case report

BACKGROUND Cardiac resynchronization therapy(CRT)is a well-established therapy for patients with cardiomyopathy.CASE SUMMARY The patient underwent left bundle branch area and left ventricular(reaching the left ventricular lateral vein through the coronary sinus)pacing.The optimal CRT was performed under the right bundle branch of the patient by adjusting the optimal a-v and v-v interphases to achieve the maximal benefit of the treatment.CONCLUSION The patient was diagnosed with left bundle branch block and heart failure.A left bundle branch area pacemaker assisted in correcting the complete left bundle branch block.However,the shorter QRS wave shape after pacemaker implantation through the left bundle branch area indicated a complete right bundle branch block pattern.Hence,the left bundle branch area pacemaker is not always considered as the optimal treatment.The left bundle branch pacing with the optimization of cardiac resynchronization treatment may serve as a new CRT strategy.

Mechanistic Insights into the Shear Effects on Isotactic Polypropylene Crystallization Containingβ-Nucleating Agent

The crystalline structures and crystallization behaviors of iPP containing β nucleation agent TMB-5 （iPP/TMB-5） were investigated by synchrotron radiation wide angel X-ray diffraction （SR-WAXD）, differential scanning calorimeter （DSC） and polarized light microscope （PLM）. It was found that α-crystallization lagged behind β-crystallization at normal temperatures, but the discrepancy reduced with increasing temperature. TMB-5 could not induce β-iPP when the nucleation agent is wrapped up with α-crystal that crystallized at high temperatures. The polymorphic composition of iPP/TMB-5 was susceptible to the introductory moment of shear. New crystallization process of β-nucleated iPP was proposed to understand the experimental phenomena which could not be explained by those reported in the literature. It was supposed that polymer crystallization initiated from mesophase, and the formations of iPP crystals involved the organization of helical conformation ordering within rnesophase. It was proposed that the iPP melt contained mesophases with stereocomplex-type ordering of right-handed and left-handed helical chains which could be disturbed by shear or TMB-5, leading to different polymorphic structures.

Enhanced 1.54-μm photo-and electroluminescence based on a perfluorinated Er(Ⅲ) complex utilizing an iridium(Ⅲ) complex as a sensitizer

Advanced 1.5-μm emitting materials that can be used to fabricate electrically driven light-emitting devices have the potential for developing cost-effective light sources for integrated silicon photonics.Sensitized erbium(Er^(3+))in organic materials can give bright 1.5-μm luminescence and provide a route for realizing 1.5-μm organic light emitting diodes(OLEDs).However,the Er3+electroluminescence(EL)intensity needs to be further improved for device applications.Herein,an efficient 1.5-μm OLED made from a sensitized organic Er3+co-doped system is realized,where a“traditional”organic phosphorescent molecule with minimal triplet–triplet annihilation is used as a chromophore sensitizer.The chromophore provides efficient sensitization to a co-doped organic Er^(3+) complex with a perfluorinatedligand shell.The large volume can protect the Er^(3+) 1.5-μm luminescence from vibrational quenching.The average lifetime of the sensitized Er^(3+) 1.5-μm luminescence reaches ~0.86 ms,with a lifetime component of 2.65 ms,which is by far the longest Er^(3+) lifetime in a hydrogen-abundant organic environment and can even compete with that obtained in the fully fluorinated organic Er^(3+) system.The optimal sensitization enhances the Er^(3+) luminescence by a factor of 1600 even with a high concentration of the phosphorescent molecule,and bright 1.5-μm OLEDs are obtained.

MORN3：MEIG1的分子伴侣在小鼠生精细胞中的表达

Mammalian spermatogenesis is a well-organized process of cell development and differentiation. Meiosis expressed gene I （MEIG 1） plays an essential role in the regulation of spermiogenesis. To explore potential mechanisms of MEIGI＇s action, a yeast two-hybrid screen was conducted, and several potential binding partners were identified; one of them was membrane occupation and recognition nexus repeat containing 3 （MORN3）. MORN3 mRNA is only abundant in mouse testis. In the testis, Morn3 mRNA is highly expressed in the spermiogenesis stage. Specific anti-MORN3 polyclonal antibody was generated against N-terminus of the full-length MORN3 protein, and MORN3 expression and localization was examined in vitro and in vivo. In transfected Chinese hamster ovary cells, the antibody specifically crossed-reacted the full-length MORN3 protein, and immunofluorescence staining revealed that MORN3 was localized throughout the cytoplasm. Among multiple mouse tissues, about 25 kDa protein, was identified only in the testis. The protein was highly expressed after day 20 of birth. Immunofluorescence staining on mixed testicular cells isolated from adult wild-type mice demonstrated that MORN3 was expressed in the acrosome in germ cells throughout spermiogenesis. The protein was also present in the manchette of elongating spermatids. The total MORN3 expression and acrosome localization were not changed in the Meig/-deficient mice. However, its expression in manchette was dramatically reduced in the mutant mice. Our studies suggest that MORN3 is another regulator for spermatogenesis, probably together with MEIG1.